Literature DB >> 28137984

Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.

Edwin K Jackson1, Yumeng Zhang2, Dongmei Cheng2.   

Abstract

Tissue nonspecific alkaline phosphatase (TNAP) contributes to the production of adenosine by the kidney, and A1-receptor activation enhances renovascular responses to norepinephrine. Therefore, we hypothesized that TNAP regulates renovascular responsiveness to norepinephrine. In isolated, perfused rat kidneys, the TNAP inhibitor l-p-bromotetramisole (0.1 mmol/L) decreased renal venous levels of 5'-AMP (adenosine precursor) and adenosine by 61% (P<0.0384) and 62% (P=0.0013), respectively, at 1 hour into treatment and caused a 10-fold rightward shift of the concentration-response relationship to exogenous norepinephrine (P<0.0001). Similarly, 2 other TNAP inhibitors, levamisole (1 mmol/L) and 2,5-dimethoxy-N-(quinolin-3-yl)benzenesulfonamide (0.02 mmol/L), also right shifted the concentration-response relationship to norepinephrine. The ability of TNAP inhibition to blunt renovascular responses to norepinephrine was mostly prevented or reversed by restoring A1-adenosinergic tone with the A1-receptor agonist 2-chloro-N6-cyclopentyladenosine (100 nmol/L). All 3 TNAP inhibitors also attenuated renovascular responses to renal sympathetic nerve stimulation, suggesting that TNAP inhibition attenuates renovascular responses to endogenous norepinephrine. In control propranolol-pretreated rats, acute infusions of norepinephrine (10 μg/kg/min) increased mean arterial blood pressure from 95±5 mm Hg to a peak of 169±4 mm Hg and renovascular resistance from 12±2 mm Hg/mL/min to a peak of 55±12 mm Hg/mL/min; however, in rats also treated with intravenous l-p-bromotetramisole (30 mg/kg), the pressor and renovascular effects of norepinephrine were significantly attenuated (blood pressure: basal and peak, 93±7 and 146±6 mm Hg, respectively; renovascular resistance: basal and peak, 13±2 and 29±5 mm Hg/mL/min, respectively). TNAP inhibitors attenuate renovascular and blood pressure responses to norepinephrine, suggesting that TNAP participates in the regulation of renal function and blood pressure.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  adenosine; adenosine receptors; alkaline phosphatase; kidney; norepinephrine; vasoconstriction

Mesh:

Substances:

Year:  2017        PMID: 28137984      PMCID: PMC5310812          DOI: 10.1161/HYPERTENSIONAHA.116.08623

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  46 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

2.  Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney.

Authors:  Edwin K Jackson; Dongmei Cheng; Zaichuan Mi; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

3.  Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.

Authors:  K O Sedaa; R A Bjur; K Shinozuka; D P Westfall
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

4.  The cytochemical application of new potent inhibitors of alkaline phosphatases.

Authors:  M Borgers
Journal:  J Histochem Cytochem       Date:  1973-09       Impact factor: 2.479

5.  Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters.

Authors:  P Sneddon; G Burnstock
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

6.  A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins.

Authors:  E K Jackson; W B Campbell
Journal:  Hypertension       Date:  1981 Jan-Feb       Impact factor: 10.190

7.  Extracellular adenosine signaling in molecular medicine.

Authors:  Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2013-02       Impact factor: 4.599

8.  Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Authors:  Russell Dahl; Eduard A Sergienko; Ying Su; Yalda S Mostofi; Li Yang; Ana Maria Simao; Sonoko Narisawa; Brock Brown; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H Smith; W Charles O'Neill; José Luis Millán; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

9.  Isolation and culture of rat microvascular endothelial cells.

Authors:  Cynthia A Frye; Charles W Patrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

10.  Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney.

Authors:  Edwin K Jackson; Dongmei Cheng; Zaichuan Mi; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Physiol Rep       Date:  2013-08-20
View more
  2 in total

1.  Alkaline Phosphatase Activity Is a Key Determinant of Vascular Responsiveness to Norepinephrine.

Authors:  Edwin K Jackson; Dongmei Cheng; Vladimir B Ritov; Zaichuan Mi
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

Review 2.  Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.

Authors:  Mathias Haarhaus; Dean Gilham; Ewelina Kulikowski; Per Magnusson; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.